Literature DB >> 3937610

[Concerning an implantable contraceptive: a memorandum of a WHO meeting].

.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 3937610      PMCID: PMC2536450     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  30 in total

1.  Perception and acceptability of NORPLANT implants in Thailand.

Authors:  S Satayapan; K Kanchanasinith; S Varakamin
Journal:  Stud Fam Plann       Date:  1983 Jun-Jul

2.  NORPLANT implants and the TCu 200 IUD: a comparative study in Ecuador.

Authors:  P Marangoni; S Cartagena; J Alvarado; J Díaz; A Faúndes
Journal:  Stud Fam Plann       Date:  1983 Jun-Jul

3.  A prospective study of NORPLANT implants and the TCu 380AgIUD in Assiut, Egypt.

Authors:  M M Shaaban; M Salah; A Zarzour; S A Abdullah
Journal:  Stud Fam Plann       Date:  1983 Jun-Jul

4.  A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).

Authors:  S Diaz; M Pavez; P Miranda; D N Robertson; I Sivin; H B Croxatto
Journal:  Contraception       Date:  1982-05       Impact factor: 3.375

5.  Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate.

Authors:  B M Landgren; E Johannisson; B Masironi; E Diczfalusy
Journal:  Contraception       Date:  1982-12       Impact factor: 3.375

6.  Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.

Authors:  D N Robertson; I Sivin; H A Nash; J Braun; J Dinh
Journal:  Contraception       Date:  1983-05       Impact factor: 3.375

7.  The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels.

Authors:  S J Ory; C B Hammond; S G Yancy; R W Hendren; C G Pitt
Journal:  Am J Obstet Gynecol       Date:  1983-03-01       Impact factor: 8.661

8.  Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.

Authors:  H B Croxatto; S Diaz; D N Robertson; M Pavez
Journal:  Contraception       Date:  1983-03       Impact factor: 3.375

9.  Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.

Authors:  F Alvarez; V Brache; A Faundes; E D Johansson; V Odlind; H Nash
Journal:  Contraception       Date:  1983-02       Impact factor: 3.375

10.  Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.

Authors:  B Düsterberg; M Hümpel; U Speck
Journal:  Contraception       Date:  1981-12       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.